IMRIS (IMRSQ) ROCE %: -60.53% (As of Dec. 2014)


What is IMRIS ROCE %?

IMRIS IMRSQ ROCE % is -60.53% as of Dec. 2014.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IMRIS's annualized ROCE % for the quarter that ended in Dec. 2014 was -60.53%.

IMRIS  (OTCPK:IMRSQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IMRIS ROCE % Related Terms

IMRIS ROCE % Historical Data

* Premium members only.

The historical data trend for IMRIS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS ROCE % Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
ROCE %
Get a 7-Day Free Trial Premium Member Only -1.35 -19.66 -38.14 -75.03 -55.89

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -122.32 -50.31 -51.45 -72.55 -60.53

IMRIS ROCE % Calculation

IMRIS's annualized ROCE % for the fiscal year that ended in Dec. 2014 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2014 )  (A: Dec. 2013 )(A: Dec. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2014 )  (A: Dec. 2013 )(A: Dec. 2014 )
=-25.568/( ( (85.561 - 27.835) + (65.484 - 31.723) )/ 2 )
=-25.568/( (57.726+33.761)/ 2 )
=-25.568/45.7435
=-55.89 %

IMRIS's ROCE % of for the quarter that ended in Dec. 2014 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2014 )  (Q: Sep. 2014 )(Q: Dec. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2014 )  (Q: Sep. 2014 )(Q: Dec. 2014 )
=-21.34/( ( (59.532 - 22.787) + (65.484 - 31.723) )/ 2 )
=-21.34/( ( 36.745 + 33.761 )/ 2 )
=-21.34/35.253
=-60.53 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2014) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -60.53% mean?
IMRIS (IMRSQ) has a ROCE % of -60.53% as of Dec. 2014.
Is IMRIS's ROCE % too high?
IMRIS's current ROCE % is -60.53%.
How does IMRIS's ROCE % compare to IVOB and IGNG?
IMRIS's ROCE % of -60.53% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMRIS's current ROCE % is -60.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMRIS stock overvalued right now?
IMRIS (IMRSQ) has a current ROCE % of -60.53%. The current ROCE % is -60.53%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For IMRIS (IMRSQ), the current ROCE % is -60.53% as of Dec. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMRIS Business Description

Address 1230 Chaska Creek Way, Suite 100, Chaska, MN, USA, 55318
IMRIS Inc provides integrated intraoperative imaging environments that deliver real-time MRI and imaging data during surgical and interventional procedures. The Operating Suite of the company enables imaging directly within the OR, enhancing clinical decision-making. The company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables tailored for this specialized setting.